ClinicalTrials.govpublic full text
Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks
obesity, hunger, sodium-dependent glucose transporter, gw869682, body composition, sglt2 inhibitor, weight loss, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805377
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.